Fc fusion proteins: a multifunctional recombinant protein platform from affinity purification to functional research

Author: Senior Product Manager of UA Views：8

This article focuses on the molecular characteristics and biological functions of Fc fusion proteins, systematically elaborating on the structural composition and dimerization mechanisms of IgG antibody constant fragments as affinity tags, analyzing the technical advantages of Fc fusion proteins in improving solubility, extending half-life, enhancing expression and secretion, and facilitating detection and purification, and discussing the broad applications of Fc fusion proteins in drug discovery, drug delivery, vaccine design, and receptor-ligand interaction research.

Recent Advances
Product Information

Recent Advances

Fc Chimera Proteins: A Multifunctional Recombinant Protein Platform from Affinity Purification to Functional Research

Brief introduction: This article focuses on the molecular characteristics and biological functions of Fc chimera proteins, systematically elaborating on the structural composition and dimerization mechanism of the IgG antibody constant fragment as an affinity tag, analyzing the technical advantages of Fc fusion proteins in improving solubility, extending half-life, enhancing expression and secretion, and facilitating detection and purification, and discussing the broad applications of Fc chimera proteins in drug discovery, drug delivery, vaccine design, and receptor-ligand interaction research.

I. Molecular Structure and Dimerization Design of Fc Chimera Proteins.

The constant fragment of IgG antibodies is a novel and convenient affinity tag that can facilitate the detection, purification, and localization of proteins, and positively influence protein yield, solubility, stability, folding, and even activity. The Fc tag typically has two heavy-chain constant region domains and a hinge region. It usually causes the recombinant protein to dimerize after being expressed as an antibody-like molecule, and provides high-affinity interactions between the fusion protein and its receptor. Similar to antibody molecules, Fc-tagged monomers are connected via disulfide bonds. The flexible hinge region facilitates the correct folding of Fc fusion proteins and enables the Fc and target protein to function independently. This molecular architecture of a “disulfide-bonded dimerization core with flexible hinge-connected functional modules” is the structural basis that distinguishes Fc chimera proteins from other tag fusion proteins——it provides both a stable protein scaffold and preserves the conformational freedom for the target protein to independently exert its function.

II. Core Technical Advantages of the Fc Tag.

Overall, the Fc tag offers multiple advantages for fusion proteins. At the structural level, the Fc fragment can mediate dimerization and multimerization, enabling the fusion protein to exist in dimeric form, which more closely resembles the multivalent binding state of natural receptors, thereby improving binding affinity to ligands. The introduction of the flexible hinge region increases molecular flexibility, allowing the Fc domain and the target protein to each maintain correct folding and function. At the stability level, Fc fusion can improve the stability and solubility of recombinant proteins, increase the expression or secretion levels of recombinant proteins, and significantly extend serum half-life in vivo——this property stems from the binding of the Fc fragment to the neonatal Fc receptor, enabling the fusion protein to escape lysosomal degradation and recycle back to the cell surface.

At the detection and purification level, the Fc tag has strong specificity and allows easy purification of recombinant proteins via protein A or protein G affinity chromatography, and anti-IgG antibodies can serve as tag antibodies for detecting the expression of recombinant Fc fusion proteins, making it suitable for novel recombinant proteins for which specific antibodies are not yet available. At the functional level, the Fc fragment can also participate in the transmission of activating and inhibitory signals, as well as biological effects such as activation or inhibition of cytokine secretion. The superposition of these advantages makes the Fc tag a multifunctional platform combining structural support, purification convenience, and functional regulation.

III. Expression Identification and Detection Strategies for Fc Fusion Proteins.

For novel recombinant proteins for which no antibody is available to determine protein expression, anti-IgG antibodies can serve as tag antibodies for detecting the expression of recombinant Fc fusion proteins. The practicality of this detection strategy lies in the fact that the Fc sequence is highly conserved and anti-IgG antibodies are widely available, so researchers do not need to separately prepare specific antibodies for each new fusion protein, and can confirm the expression and integrity of the fusion protein through methods such as immunoblotting, enzyme-linked immunosorbent assay, or flow cytometry. In expression identification, it is usually necessary to simultaneously set up an empty vector control and a non-transfected cell control to distinguish specific bands from non-specific background. For secreted Fc fusion proteins, the secretion efficiency can also be evaluated by detecting the Fc signal in the culture supernatant. This generalized detection pathway significantly reduces the technical threshold and cost of early-stage characterization of novel fusion proteins.

IV. Applications of Fc Chimera Proteins in Drug Discovery and Basic Research.

Fc fusion proteins are widely used in drug discovery, drug delivery, vaccine design, and experimental research on receptor-ligand interactions. In drug discovery, Fc fusion can extend the half-life of candidate molecules and improve their pharmacokinetic properties, making short-half-life ligands or receptor extracellular domains viable therapeutic molecules. In drug delivery, the Fc fragment can serve as a carrier module fused with targeting ligands to achieve targeted drug delivery. In vaccine design, Fc fusion can enhance the immunogenicity and stability of antigens. In receptor-ligand interaction research, Fc chimera proteins exist in dimeric form, more closely resembling the multivalent binding state of natural receptors, and can be used to determine binding kinetic parameters by surface plasmon resonance or bio-layer interferometry. These application scenarios collectively reflect the complete chain of Fc chimera proteins extending from basic mechanism analysis to translational medicine tools.

V. Conclusion.

As a multifunctional recombinant protein platform combining structural support, purification convenience, and functional regulation, Fc chimera proteins, with their dimerization architecture composed of CH2 and CH3 domains and a hinge region, multiple technical advantages in improving solubility and stability, extending serum half-life, and enhancing expression and secretion, as well as experimental convenience through convenient purification via protein A or protein G affinity chromatography and generalized detection with anti-IgG antibodies, have become core tools widely used in drug discovery, drug delivery, vaccine design, and receptor-ligand interaction research. From the multivalent binding advantages brought by dimerization to the functional independence ensured by the flexible hinge, from the generalized pathway of expression identification to the half-life extension strategy in drug development, Fc chimera proteins continue to drive the transformation of recombinant protein tools toward therapeutic molecules. The CD19 Fc Chimera Protein, Human provided by Univ contributes reliable tool support for mechanism research and targeted drug development of B cell-related targets, and will continue to facilitate innovative exploration in the field of immunotherapy.

This article is reviewed and published by the technical expert team of UA

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Nanjing Univ is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience

Nanjing UNIV Biotechnology Co., Ltd. Email：order@ua-bio.com Phone：+86-25-56221161

more products

Product Information

The Next